Opus Genetics IRD
NASDAQ IRD
$3.47 -0.35 (-9.16%)
At close: Oct 23, 2026 · 4:00 PM EDT

Opus Genetics (IRD) Gains from Investment Securities (2011 - 2026)

Updated

Analysis

Opus Genetics (IRD) Gains from Investment Securities (2011 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn
10 Opus Genetics 333.24 Mn 108.52 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 7.46 Mn
Mar 31, 2026 -51.36 Mn
Dec 31, 2025 -5.71 Mn
Sep 30, 2025 -9.53 Mn
Jun 30, 2025 917,000.00
Mar 31, 2025 2.81 Mn
Dec 31, 2024 84,000.00
Mar 31, 2024 -10,000.00
Dec 31, 2023 19,000.00
Sep 30, 2023 61,000.00
Mar 31, 2023 -27,000.00
Dec 31, 2022 -52,000.00
Mar 31, 2022 -84,000.00
Mar 31, 2021 -33.83 Mn
Dec 31, 2020 -1.64 Mn
Sep 30, 2020 879,000.00
Jun 30, 2020 -919,000.00
Mar 31, 2020 198,000.00
Jun 30, 2011 -3,960.00
API Access

Opus Genetics Gains from Investment Securities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-investment-securities&ticker=IRD&period=max&api_key=YOUR_API_KEY